StockData
Neogen Corp logo

Neogen Corp (NEOG) stock

NEOGNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 7, 2026Score 7/3049% above fair value
$10.55−0.30 (-2.76%)

Close on Nov 20, 2026Market cap $2.30BP/E –Yield –

Neogen shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Neogen's shares outstanding was 218M at Aug 31, 2026. For fiscal 2026 it was 218M, up 0.3% from the year before. Over ten years it grew 8.0% a year on average. The highest annual figure on record is 218M in fiscal 2026.

Annual shares outstanding

PeriodPeriod endValueChange
FY2026May 31, 2026218M+0.3%
FY2025May 31, 2025217M+0.2%
FY2024May 31, 2024217M+14.6%
FY2023May 31, 2023189M+74.9%
FY2022May 31, 2022108M+0.8%
FY2021May 31, 2021107M+1.3%
FY2020May 31, 2020106M+0.8%
FY2019May 31, 2019105M+0.5%
FY2018May 31, 2018104M+1.9%
FY2017May 31, 2017102M+1.3%
FY2016May 31, 2016101M+1.2%
FY2015May 31, 2015100M+0.5%
FY2014May 31, 201499M+2.1%
FY2013May 31, 201397M+1.3%
FY2012May 31, 201296M+1.0%
FY2011May 31, 201195M+3.0%
FY2010May 31, 201092M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Aug 31, 2026218M+0.4%
Q4 FY2026CQ2 2026May 31, 2026216M-0.4%
Q3 FY2026CQ1 2026Feb 28, 2026218M+0.3%
Q2 FY2026CQ4 2025Nov 30, 2025217M+0.3%
Q1 FY2026CQ3 2025Aug 31, 2025217M+0.3%
Q4 FY2025CQ2 2025May 31, 2025217M+0.2%
Q3 FY2025CQ1 2025Feb 28, 2025217M+0.2%
Q2 FY2025CQ4 2024Nov 30, 2024217M+0.2%
Q1 FY2025CQ3 2024Aug 31, 2024217M-0.1%
Q4 FY2024CQ2 2024May 31, 2024217M+0.1%
Q3 FY2024CQ1 2024Feb 29, 2024217M+0.1%
Q2 FY2024CQ4 2023Nov 30, 2023216M+0.1%
Q1 FY2024CQ3 2023Aug 31, 2023217M+101.0%
Q4 FY2023CQ2 2023May 31, 2023217M+101.1%
Q3 FY2023CQ1 2023Feb 28, 2023216M+100.1%
Q2 FY2023CQ4 2022Nov 30, 2022216M+99.9%
Q1 FY2023CQ3 2022Aug 31, 2022108M-0.2%
Q4 FY2022CQ2 2022May 31, 2022108M-0.4%
Q3 FY2022CQ1 2022Feb 28, 2022108M+0.7%
Q2 FY2022CQ4 2021Nov 30, 2021108M+1.2%
Q1 FY2022CQ3 2021Aug 31, 2021108M+1.4%
Q4 FY2021CQ2 2021May 31, 2021108M+1.9%
Q3 FY2021CQ1 2021Feb 28, 2021107M+1.2%
Q2 FY2021CQ4 2020Nov 30, 2020107M+1.0%
Q1 FY2021CQ3 2020Aug 31, 2020107M+1.1%
Q4 FY2020CQ2 2020May 31, 2020106M+1.4%
Q3 FY2020CQ1 2020Feb 29, 2020106M+1.1%
Q2 FY2020CQ4 2019Nov 30, 2019106M+0.5%
Q1 FY2020CQ3 2019Aug 31, 2019105M-0.2%
Q4 FY2019CQ2 2019May 31, 2019105M-0.4%
Q3 FY2019CQ1 2019Feb 28, 2019105M+0.4%
Q2 FY2019CQ4 2018Nov 30, 2018105M+1.2%
Q1 FY2019CQ3 2018Aug 31, 2018106M+2.4%
Q4 FY2018CQ2 2018May 31, 2018105M+2.7%
Q3 FY2018CQ1 2018Feb 28, 2018104M+1.7%
Q2 FY2018CQ4 2017Nov 30, 2017104M+1.9%
Q1 FY2018CQ3 2017Aug 31, 2017103M–
Q4 FY2017CQ2 2017May 31, 2017102M–
Q3 FY2017CQ1 2017Feb 28, 2017103M–
Q2 FY2017CQ4 2016Nov 30, 2016102M–

More Neogen figures

See a number that looks wrong?